BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,061 filers reported holding BAXTER INTL INC in Q2 2019. The put-call ratio across all filers is 1.42 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $721,000 | -1.2% | 8,523 | -6.0% | 0.19% | -5.9% |
| Q4 2020 | $730,000 | -15.0% | 9,063 | -14.9% | 0.20% | -23.0% |
| Q3 2020 | $859,000 | -7.4% | 10,654 | -0.9% | 0.26% | -14.5% |
| Q2 2020 | $928,000 | +6.1% | 10,751 | +0.0% | 0.31% | -14.4% |
| Q1 2020 | $875,000 | -2.9% | 10,750 | 0.0% | 0.36% | +16.8% |
| Q4 2019 | $901,000 | -6.3% | 10,750 | -2.0% | 0.31% | -12.9% |
| Q3 2019 | $962,000 | +0.4% | 10,966 | -6.0% | 0.36% | -0.3% |
| Q2 2019 | $958,000 | +0.7% | 11,669 | +0.0% | 0.36% | +0.8% |
| Q1 2019 | $951,000 | +22.4% | 11,668 | -1.2% | 0.35% | +9.9% |
| Q4 2018 | $777,000 | -22.8% | 11,812 | -9.7% | 0.32% | -9.8% |
| Q3 2018 | $1,007,000 | +4.0% | 13,074 | 0.0% | 0.36% | -3.5% |
| Q2 2018 | $968,000 | +17.8% | 13,074 | +0.8% | 0.37% | +11.1% |
| Q1 2018 | $822,000 | -5.3% | 12,973 | -3.2% | 0.33% | -7.2% |
| Q4 2017 | $868,000 | -8.7% | 13,397 | -11.4% | 0.36% | -12.9% |
| Q3 2017 | $951,000 | -3.5% | 15,117 | -6.9% | 0.41% | -5.7% |
| Q2 2017 | $985,000 | +6.5% | 16,241 | -2.2% | 0.44% | +6.8% |
| Q1 2017 | $925,000 | +8.1% | 16,611 | -5.0% | 0.41% | +8.5% |
| Q4 2016 | $856,000 | -10.5% | 17,486 | -13.0% | 0.38% | -50.1% |
| Q3 2016 | $956,000 | – | 20,088 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tavio Capital LLC | 68,405 | $5,890,000 | 7.81% |
| Iron Triangle Partners LP | 330,000 | $28,413,000 | 7.16% |
| Veritas Asset Management LLP | 8,942,428 | $769,943,000 | 5.64% |
| TSFG, LLC | 93,405 | $8,042,000 | 5.31% |
| GENERATION INVESTMENT MANAGEMENT LLP | 10,606,094 | $913,185,000 | 5.27% |
| Third Point | 4,000,000 | $344,400,000 | 4.72% |
| Avidity Partners Management LP | 800,900 | $68,957,000 | 4.42% |
| Palmer Knight Co | 62,275 | $5,362,000 | 4.17% |
| Eos Focused Equity Management, L.P. | 36,786 | $3,167,000 | 3.70% |
| Dundas Partners LLP | 196,133 | $16,887,000 | 3.69% |